Cargando…
Declining Course of Humoral Immune Response in Initially Responding Kidney Transplant Recipients after Repeated SARS-CoV-2 Vaccination
The immunogenicity of SARS-CoV-2 vaccines in kidney transplant recipients is limited, resulting in inadequately low serological response rates and low immunoglobulin (Ig) levels, correlating with reduced protection against death and hospitalization from COVID-19. We retrospectively examined the time...
Autores principales: | Ronicke, Simon, Osmanodja, Bilgin, Budde, Klemens, Jens, Annika, Hammett, Charlotte, Koch, Nadine, Zukunft, Bianca, Bachmann, Friederike, Choi, Mira, Weber, Ulrike, Eberspächer, Bettina, Hofmann, Jörg, Grunow, Fritz, Mikhailov, Michael, Halleck, Fabian, Schrezenmeier, Eva |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9224612/ https://www.ncbi.nlm.nih.gov/pubmed/35743365 http://dx.doi.org/10.3390/jcm11123291 |
Ejemplares similares
-
Serological Response to Three, Four and Five Doses of SARS-CoV-2 Vaccine in Kidney Transplant Recipients
por: Osmanodja, Bilgin, et al.
Publicado: (2022) -
Poor Outcomes in Patients With Transplant Glomerulopathy Independent of Banff Categorization or Therapeutic Interventions
por: Wu, Kaiyin, et al.
Publicado: (2022) -
COVID-19 Outcomes in Kidney Transplant Recipients in a German Transplant Center
por: Mikhailov, Michael, et al.
Publicado: (2023) -
Poor Long-Term Renal Allograft Survival in Patients with Chronic Antibody-Mediated Rejection, Irrespective of Treatment—A Single Center Retrospective Study
por: Wu, Kaiyin, et al.
Publicado: (2021) -
Temporary antimetabolite treatment hold boosts SARS-CoV-2 vaccination–specific humoral and cellular immunity in kidney transplant recipients
por: Schrezenmeier, Eva, et al.
Publicado: (2022)